118 related articles for article (PubMed ID: 12150518)
1. Human leukocyte antigens and prognosis in patients with head and neck cancer: results of a prospective follow-up study.
Tisch M; Kyrberg H; Weidauer H; Mytilineos J; Conradt C; Opelz G; Maier H
Laryngoscope; 2002 Apr; 112(4):651-7. PubMed ID: 12150518
[TBL] [Abstract][Full Text] [Related]
2. Changes in presentation and survival of head and neck carcinomas in Northeastern Italy, 1975-1998.
Barzan L; Talamini R; Franchin G; Vaccher E; Politi D; Minatel E; Gobitti C
Cancer; 2002 Aug; 95(3):540-52. PubMed ID: 12209746
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for head and neck cancer.
Gleich LL
Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
[TBL] [Abstract][Full Text] [Related]
4. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
5. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
7. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
8. HER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma.
Tse GM; Yu KH; Chan AW; King AD; Chen GG; Wong KT; Tsang RK; Chan AB
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):467-73. PubMed ID: 19786214
[TBL] [Abstract][Full Text] [Related]
9. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
Wolf GT; Carey TE
J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
[TBL] [Abstract][Full Text] [Related]
10. [Stage grouping for head and neck cancer: a meta-analysis].
Pastore A; Calura G; Carinci F
Minerva Stomatol; 2001; 50(9-10):285-98. PubMed ID: 11723428
[TBL] [Abstract][Full Text] [Related]
11. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
12. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
[TBL] [Abstract][Full Text] [Related]
13. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
[TBL] [Abstract][Full Text] [Related]
14. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging.
Ljumanovic R; Langendijk JA; Hoekstra OS; Leemans CR; Castelijns JA
Eur J Radiol; 2006 Oct; 60(1):58-66. PubMed ID: 16829010
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
Argiris A; Li Y; Forastiere A
Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas].
Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285
[TBL] [Abstract][Full Text] [Related]
18. Comparison of surface HLA class I levels in squamous cell carcinoma cell lines of the head and neck.
Mandic R; Lieder A; Sadowski M; Peldszus R; Werner JA
Anticancer Res; 2004; 24(2B):973-9. PubMed ID: 15161052
[TBL] [Abstract][Full Text] [Related]
19. Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality.
Rusthoven KE; Raben D; Chen C
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):343-50. PubMed ID: 18374508
[TBL] [Abstract][Full Text] [Related]
20. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
